The mission of the Melanoma Research Alliance (MRA) is to end suffering and death due to melanoma by collaborating with all stakeholders to accelerate powerful research, advance cures for all patients, and prevent more melanomas.
Each of GlobalGiving’s nonprofit partners is required to send quarterly donor reports detailing the impact of their work. Here are some of their recent updates:
By Janine Rauscher | Director, Development Operations
Every hour, someone in the United States dies from melanoma. It remains the deadliest form of skin cancer—even as melanoma research has transformed cancer care for millions worldwide. Melanoma... Read the full report ›By Janine Rauscher | Director, Development Operations
As we approach another Melanoma Awareness Month, our collective commitment to discovery that will help end death and suffering due to melanoma remains unwavering. Over the past two decades, the... Read the full report ›By Marc Hulbert | Chief Executive Officer
The Melanoma Research Alliance (MRA) and our collaborators at the Veterans Administration (VA) Hospitals in Boston and Providence, and at Massachusetts General Hospital (MGH), have assembled the... Read the full report ›
